多学科协作治疗Ⅳ期结肠癌患者一例

病例讨论

多学科协作治疗Ⅳ期结肠癌患者一例

吴佳阳¹, 张睿¹^,^†(

)

全文 ( ) 下载PDF ( ) 导出引用

图1 结肠癌肝转移患者新辅助治疗前与新辅助治疗4周期和8周期后的腹部CT图像，显示肝转移病灶明显缩小

图2 结肠癌肝转移患者乙状结肠原发病灶在新辅助治疗前后结肠镜检查图像

图3 结肠癌肝转移患者光镜下病理检查图像

[1]	Schuhmacher C,Fink U,Siewert JR, et al.Preoperative dowmstaging in advanced stomach carcinnoma.Wishful thinking or reality.Zentralbl Chir, 2000, 125(4): 333-334.
[2]	Lièvre A,Bachet JB,Boige V, et al.KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.J Clin Oncol, 2008, 26: 374-379.
[3]	Tabernero J,Pfeiffer P,Cervantes A. Administration of Cetuximab Every 2 Weeks in the Treatment of Metastatic Colorectal Cancer: An Effective, More Convenient Alternative to Weekly Administration.Oncologist, 2008, 13(2): 113-119.
[4]	Adam R. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases.Ann Oncol, 2003, 14: ii13-ii16.
[5]	Chiappa A,Zbar AP,Biella F, et al.Survival after repeat hepatic resection for recurrent colorectal metastases.Hepato gastroenterology, 1999, 46: 1065-1070.

No related articles found!

阅读次数

全文

摘要